Resection of post-chemotherapy residual masses (RMs) in patients with advanced non-seminomatous germ cell tumors (NSGCT): prediction of outcomes

被引:0
|
作者
Mediano Rambla, M. [1 ]
Thiery-Vuillemin, A. [2 ]
Alonso, M. [1 ]
Ocon, E. [1 ]
Conde, M. [1 ]
Sancho, P. [1 ]
Osman, I. [1 ]
Robles, C. [1 ]
Medina, R. [1 ]
Duran, I. [1 ]
机构
[1] HHUU Virgen del Rocio, Seville, Spain
[2] CHU Minjoz, Besancon, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2723
引用
收藏
页码:S650 / S650
页数:1
相关论文
共 50 条
  • [31] Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: A single-surgeon, Canadian experience
    King, Joshua
    Kawakami, Jun
    Heng, Daniel
    Gan, Chun Loo
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (09): : E407 - E411
  • [32] ROBOT-ASSISTED LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMATOUS GERM CELL TUMORS IN THE POST-CHEMOTHERAPY SETTING
    Marshall, Michael
    Abdul-Muhsin, Haidar
    Stroup, Sean
    Woods, Michael
    Porter, James
    Castle, Erik
    L'Esperance, James
    JOURNAL OF UROLOGY, 2016, 195 (04): : E771 - E772
  • [33] POST-CHEMOTHERAPY LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMATOUS GERM CELL TESTICULAR TUMOR
    Knezevic, N.
    Kulis, T.
    Bernat, M.
    Krhen, I
    Goluza, E.
    Kastelan, Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 319 - 320
  • [34] POST-CHEMOTHERAPY SURGERY IN ADVANCED NON-SEMINOMATOUS GERM-CELL TESTICULAR-TUMORS - THE SIGNIFICANCE OF HISTOLOGY WITH PARTICULAR REFERENCE TO DIFFERENTIATED (MATURE) TERATOMA
    TAIT, D
    PECKHAM, MJ
    HENDRY, WF
    GOLDSTRAW, P
    BRITISH JOURNAL OF CANCER, 1984, 50 (05) : 601 - 609
  • [35] The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derig, HG
    De Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, WE
    Gerhartz, HH
    Kirchner, H
    Pflüger, KH
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    EUROCANCER 98, 1998, : 321 - 323
  • [36] Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients.
    Leao, Ricardo Romao Nazario
    Van Agthoven, Ton
    Figueiredo, Arnaldo
    Fadaak, Kamel
    Castelo-Branco, Pedro
    Jewett, Michael A. S.
    Sweet, Joan
    Ahmad, Ardalan
    Anson-Cartwright, Lynn
    Bedard, Philippe L.
    Chung, Peter W. M.
    Hansen, Aaron Richard
    Warde, Padraig Richard
    O'Malley, Martin
    Looijenga, Leendert
    Hamilton, Robert James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [37] Clinical evaluation of Olympus AFP assay as an aid in the management of patients with non-seminomatous germ cell tumors (NSGCT)
    Shah, H.
    Rush, C.
    Minihan, M.
    Kenny, P.
    Davis, D.
    Loebel, J.
    Lepp, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A112
  • [38] RATES OF TERATOMA AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION BY INDUCTION CHEMOTHERAPY REGIMEN FOR GOOD RISK NON-SEMINOMATOUS GERM CELL TUMORS
    Kundu, Shilajit
    Carver, Brett
    Bajorin, Dean
    Motzer, Robert
    Bosl, George
    Feldman, Darren
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2011, 185 (04): : E334 - E334
  • [39] No need for contralateral lung surgery in case of evidence of post-chemotherapy necrosis alone in residual lung masses in patients with disseminated non seminomatous germ cell tumors.
    Besse, B
    Flechon, A
    Caty, A
    Chevreau, C
    Culine, S
    Grunenwald, D
    Fizazi, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 383S - 383S
  • [40] Can we improve the outcome of patients with advanced non-seminomatous germ cell tumors (NSGCT): 16 years experience of a single institution
    Tryakin, A.
    Tjulandin, S.
    Fedyanin, M.
    Titov, D.
    Bulanov, A.
    Garin, A.
    Figurin, K.
    Kanagavel, D.
    Sergeev, J.
    Zakharova, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)